Edition:
United Kingdom

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

10.70USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$10.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
19,626
52-wk High
$18.00
52-wk Low
$7.50

Chart for

About

Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of orphan diseases. Its pipeline includes Sarasar (lonafarnib) for hepatitis delta virus (HDV), exendin (9-39) for severe... (more)

Overall

Beta: 2.57
Market Cap(Mil.): $107.52
Shares Outstanding(Mil.): 8.37
Dividend: --
Yield (%): --

Financials

  EIGR.OQ Industry Sector
P/E (TTM): -- 85.35 33.64
EPS (TTM): -5.69 -- --
ROI: -116.96 0.18 14.27
ROE: -143.95 1.14 15.99

BRIEF-Eiger Biopharmaceuticals Announces Proposed Public Offering Of Common Stock

* EIGER BIOPHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

23 May 2018

Earnings vs. Estimates